Literature DB >> 19823067

Characteristics and management of diaphragm involvement in patients with primary advanced-stage ovarian, fallopian tube, or peritoneal cancer.

Jens Einenkel1, Rudolf Ott, Romy Handzel, Ulf-Dietrich Braumann, Lars-Christian Horn.   

Abstract

OBJECTIVES: The aim of this study was to determine the frequency of diaphragm involvement (DI) in cases of International Federation of Gynecology and Obstetrics (FIGO) stage IIIC and IV primary epithelial ovarian, fallopian tube, or peritoneal cancer; the frequency of use of different surgical techniques in managing diaphragm implants; and the procedure-associated morbidity.
METHODS: A retrospective analysis of consecutive patients undergoing primary surgery by a single surgical team between January 2005 and June 2007 was accomplished. Patients with tumors of low malignant potential and nonepithelial histologic diagnosis and those who received neoadjuvant chemotherapy were excluded.
RESULTS: Thirty-three patients met the inclusion criteria. Diaphragm involvement was found in 91% of the cases. Whereas the left hemidiaphragm is never involved alone, the right side is significantly affected more extensively (P = 0.002) and frequently (alone, 20%; both sides, 80%). The frequency of use of procedures varies considerably in the literature, whereas full-thickness diaphragm resection (DR) had to be performed in 53% of our patients with DI. Diaphragm resection at the left hemidiaphragm and bilateral DRs are very rare in primary cases. A specific histopathologic examination of the DR preparation is desirable. A simple 4-tiered classification of the infiltration depth is proposed. The most frequent complication is serothorax, but a generous indication for intraoperative chest tube placement is solely recommended in cases of DR.
CONCLUSIONS: Surgical effort in achieving an optimum cytoreduction could be evaluated more precisely with parameters of DI and diaphragm-related treatment procedures. The usual quality criteria for ovarian cancer surgery, such as residual tumor state and morbidity, are more marked by subjectivity and inconsistent definitions.

Entities:  

Mesh:

Year:  2009        PMID: 19823067     DOI: 10.1111/IGC.0b013e3181a3a833

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  9 in total

1.  S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013.

Authors:  U Wagner; P Harter; F Hilpert; S Mahner; A Reuß; A du Bois; E Petru; W Meier; P Ortner; K König; K Lindel; D Grab; P Piso; O Ortmann; I Runnebaum; J Pfisterer; D Lüftner; N Frickhofen; F Grünwald; B O Maier; J Diebold; S Hauptmann; F Kommoss; G Emons; B Radeleff; M Gebhardt; N Arnold; G Calaminus; I Weisse; J Weis; J Sehouli; D Fink; A Burges; A Hasenburg; C Eggert
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-09       Impact factor: 2.915

2.  Successful diagnosis of an occult fallopian tube carcinoma detected from the diaphragm metastasis.

Authors:  Takahide Toyoda; Hidemi Suzuki; Takahiro Nakajima; Takekazu Iwata; Ayumu Matsuoka; Kyoko Nishikimi; Yoko Yonemori; Makio Shozu; Yukio Nakatani; Ichiro Yoshino
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-01-11

3.  Association of Diaphragmatic Surgery as Part of Cytoreductive Effort in Advanced Stage Ovarian Cancer.

Authors:  Nicolae Bacalbasa; Irina Balescu; Cristian Balalau; Olivia Ionescu; Claudia Stoica
Journal:  In Vivo       Date:  2018 Mar-Apr       Impact factor: 2.155

4.  Diaphragmatic Surgery and Related Complications In Primary Cytoreduction for Advanced Ovarian, Tubal, and Peritoneal Carcinoma.

Authors:  Shuang Ye; Tiancong He; Shanhui Liang; Xiaojun Chen; Xiaohua Wu; Huijuan Yang; Libing Xiang
Journal:  BMC Cancer       Date:  2017-05-05       Impact factor: 4.430

5.  Tozzi classification of diaphragmatic surgery in patients with stage IIIC-IV ovarian cancer based on surgical findings and complexity.

Authors:  Roberto Tozzi; Federico Ferrari; Joost Nieuwstad; Riccardo Garruto Campanile; Hooman Soleymani Majd
Journal:  J Gynecol Oncol       Date:  2019-09-02       Impact factor: 4.401

6.  Pathological Characterization of Ovarian Cancer Patients Who Underwent Debulking Surgery in Combination With Diaphragmatic Surgery: A Cross-Sectional Study.

Authors:  Takeshi Nagai; Hisashi Oshiro; Yasukazu Sagawa; Kentaro Sakamaki; Fumitoshi Terauchi; Toshitaka Nagao
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

7.  Diaphragmatic smears are not of additional benefit in the detection of peritoneal spread in gynecological cancers.

Authors:  Celine Montavon; Uzma Mirza; Andre Fedier; Andreas Schoetzau; Rosanna Zanetti Dällenbach; Viola Heinzelmann-Schwarz
Journal:  Exp Ther Med       Date:  2018-03-13       Impact factor: 2.447

8.  Feasibility of laparoscopic diaphragmatic peritonectomy during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer.

Authors:  Roberto Tozzi; Hooman Soleymani Majd; Riccardo Garruto Campanile; Federico Ferrari
Journal:  J Gynecol Oncol       Date:  2020-09       Impact factor: 4.401

9.  The non-coding RNA OTUB1-isoform2 promotes ovarian tumour progression and predicts poor prognosis.

Authors:  Shunni Wang; Yan Ning; Ping Wei; Dongliag Cai; Linghui Lu; Jing Li; Yiqin Wang
Journal:  J Cell Mol Med       Date:  2018-07-25       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.